I

Initiator Pharma A/S
STO:INIT

Watchlist Manager
Initiator Pharma A/S
STO:INIT
Watchlist
Price: 7.1 SEK 2.9% Market Closed
Market Cap: 375.7m SEK
Have any thoughts about
Initiator Pharma A/S?
Write Note

Initiator Pharma A/S
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Initiator Pharma A/S
Total Receivables Peer Comparison

Comparables:
GMAB
ZEAL
ASND
B
BAVA
BIOPOR

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
I
Initiator Pharma A/S
STO:INIT
Total Receivables
kr5.4m
CAGR 3-Years
39%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Total Receivables
kr6.2B
CAGR 3-Years
36%
CAGR 5-Years
48%
CAGR 10-Years
52%
Zealand Pharma A/S
CSE:ZEAL
Total Receivables
kr245.5m
CAGR 3-Years
28%
CAGR 5-Years
77%
CAGR 10-Years
25%
Ascendis Pharma A/S
NASDAQ:ASND
Total Receivables
€80.7m
CAGR 3-Years
90%
CAGR 5-Years
99%
CAGR 10-Years
41%
B
Bavarian Nordic A/S
CSE:BAVA
Total Receivables
kr1.1B
CAGR 3-Years
44%
CAGR 5-Years
59%
CAGR 10-Years
25%
Bioporto A/S
CSE:BIOPOR
Total Receivables
kr13.4m
CAGR 3-Years
-6%
CAGR 5-Years
0%
CAGR 10-Years
3%

See Also

What is Initiator Pharma A/S's Total Receivables?
Total Receivables
5.4m DKK

Based on the financial report for Dec 31, 2023, Initiator Pharma A/S's Total Receivables amounts to 5.4m DKK.

What is Initiator Pharma A/S's Total Receivables growth rate?
Total Receivables CAGR 5Y
15%

Over the last year, the Total Receivables growth was -25%. The average annual Total Receivables growth rates for Initiator Pharma A/S have been 39% over the past three years , 15% over the past five years .

Back to Top